USFDA grants FTD to efanesoctocog alfa for hemophilia A treatment

Fast Track Designation is a process for facilitating the development and expediting the review of drugs to treat serious medical conditions. The novel and investigational factor VIII therapy

The post USFDA grants FTD to efanesoctocog alfa for hemophilia A treatment appeared first on Pharmaceutical Business review.

This is not a CAPTIS article. Originally, it was published here.